CytomX Therapeutics Lands $31,000,000 Series B Financing

  • Feed Type
  • Date
    7/31/2012
  • Company Name
    CytomX Therapeutics
  • Mailing Address
    650 Gateway Blvd South San Francisco, CA 94080
  • Company Description
    CytomX Therapeutics is an early stage, privately-funded biotechnology company developing Probodies, proteolytically-activated antibodies.
  • Website
    http://www.cytomx.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $31,000,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    Proceeds from the expanded Series B financing round will support the advancement of the company’s lead programs toward the clinic and the execution on broad business development activities aimed at the formation of key partnerships in oncology and inflammatory disease.
  • M&A Terms
  • Venture Investor
    Canaan Partners
  • Venture Investor
    Third Rock Ventures
  • Venture Investor
    Roche Venture Fund

By posting a comment, you agree to our terms and conditions.